JPMorgan Chase & Co. decreased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 27.3% during the fourth ...
Tariff Beating US Defense and Aerospace Stocks from Morningstar: “They Don’t Usually Get this Cheap”
Tariff beating stocks may be the best bets for investment for the rest of 2025, here are three from Morningstar Analyst Nicolas Owens ...
We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against ...
ANN ARBOR, Mich., March 31, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio ...
Prudential Financial Inc. lessened its stake in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 18.1% in the ...
Guggenheim lowered the firm’s price target on Twist Bioscience (TWST) to $50 from $58 and keeps a Buy rating on the shares. The firm adjusted ...
Explore more
In trading on Tuesday, shares of Twist Bioscience Corp (Symbol: TWST) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $34.35 per share. By ...
Earnings Report -0.910 USD Q4 2022 Earnings Release 11/18/2022 Earnings Report -1.080 USD Q3 2022 Earnings Release 08/05/2022 Indices Commodities Currencies Stocks ...
In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against other worst high-risk high-reward growth stocks to buy. Is the Tariff Solution ...
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results